Jade Biosciences Set for Engaging Investor Conferences Ahead

Author: Logan Wright Updated: 07-08-2025 07:17 AM

Jade Biosciences: Engaging with Investors at Conferences

Jade Biosciences, Inc. (NASDAQ: JBIO), a pioneering biotechnology firm, has announced its upcoming participation in significant investor conferences aimed at fostering dialogue about its innovative therapies for autoimmune diseases.

Highlights of Upcoming Conferences

Tom Frohlich, CEO, along with Andrew King, BVMS, Ph.D., the Chief Scientific Officer and Head of R&D, will engage in a fireside chat at the H.C. Wainwright 4th Annual Kidney Virtual Conference. This will be held on July 14, 2025, starting at 3:00 p.m. ET. Attendees can expect a live webcast available on Jade’s website's Investors & Media section, with a replay accessible for 90 days thereafter.

Following this, Mr. Frohlich and Dr. King will also participate in another fireside chat at the anticipated 2025 Stifel Biotech Summer Summit set for August 13, 2025, at 7:30 a.m. ET. This offers another excellent opportunity for investors to interact with the leaders behind Jade’s innovative approaches.

One-on-One Investor Meetings

In addition to these panels, Jade's management team will be available for one-on-one investor meetings throughout the conferences. This is an ideal chance for attendees to discuss Jade's strategic plans, potential partnerships, and the progress made with their clinical candidates.

About Jade Biosciences, Inc.

Jade Biosciences is committed to developing exceptional therapies to meet pressing needs in treating autoimmune diseases. Their leading therapeutic candidate, JADE101, focuses on the APRIL cytokine for addressing immunoglobulin A nephropathy, with the first human clinical trial planned for the latter half of 2025.

In addition to JADE101, Jade's research pipeline includes another candidate, JADE201, and an antibody discovery program, named JADE-003, currently in preclinical development. These promising therapies were developed based on assets licensed from Paragon Therapeutics, an innovator in antibody discovery founded by Fairmount.

Contact Information for Inquiries

For further inquiries or media interest regarding potential collaborations, please contact:

Priyanka Shah
Media@JadeBiosciences.com
IR@JadeBiosciences.com
908-447-6134

Frequently Asked Questions

What is Jade Biosciences known for?

Jade Biosciences develops innovative therapies targeting autoimmune diseases, with a strong focus on unmet medical needs.

When will Jade’s clinical trials begin?

The first human clinical trial for JADE101 is expected to initiate in the second half of 2025.

Who are the key figures at Jade participating in the conferences?

Tom Frohlich, CEO, and Andrew King, Chief Scientific Officer, will represent Jade at the conferences.

What are the two conferences Jade Biosciences will participate in?

Jade will engage in the H.C. Wainwright 4th Annual Kidney Virtual Conference and the 2025 Stifel Biotech Summer Summit.

How can investors connect with Jade's team?

Investors can schedule one-on-one meetings with Jade’s management team during the conferences for in-depth discussions.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.